Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

balsam Peru/castor oil/trypsin topical

balsam Peru/castor oil/trypsin topical
  • Formulary
  • Therapeutic Interchange
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Vasolex, Xenaderm OINTMENT, TOPICAL 87 mg-788 mg-90 units/g    
Granulex, TBC SPRAY, TOPICAL 72.5 mg-650 mg-0.1 mg/0.82 mL    


Comments:

Interchange orders for XENADERM/VASOLEX to Venelex

Interchange orders for GRANULEX Spray to Proderm Spray. (Proderm has also been discontinued by the manufacturer and wound care has approved Venelex as an alternative).

 

XENADERM discontinued by manufacturer August 2013.

VASOLEX discontinued by manufacturer April 2015.

GRANULEX discontinued by manufacturer December of 2015.

Updated: May 2015, April 2016


Last updated: Oct. 19, 2017







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.